Molecular Diagnostic Testing-Medicare
4Kscore Test -
Medicare
Assays of Genetic Expression in Tumor Tissue as to Determine Prognosis in Patients with Breast Cancer
-FloridaBlue-
Concurrent DNA & RNA Genetic Testing
-Humana-
Gene Expression Profile Testing & Circulating Tumor DNA Testing for Predicting Recurrence in Colon Cancer
-FloridaBlue-
Gene Expression Profiling for Prostate Cancer
Gene Mutation Testing for Solid Tumor Cancer Susceptibility & Management
-Anthem-
-Humana-
CHARGE Syndrome - Genetic Testing
-Anthem-
Genetic Testing for Inherited Diseases
-Anthem-
Genetic Testing for PTEN Hamartoma Tumor Syndrome
-Anthem-
Genotype Testing for Individual Genetic Polymorphisms to Determine Drug-Metabolizer Status
MolDX: AlloSure® Donor-Derived Cell-Free DNA Test
-Anthem-
MolDX: Circulating Tumor Cell Marker Assays
MolDX: ConfirmMDx Epigenetic Molecular Assay
MolDX: Corus CAD Assay
MolDX: CYP2C19, CYP2D6, CYP2C9, & VKORC1 Genetic Testing
MolDX: CYSTATIN C Measurement
MolDX Decipher Biopsy Prostate Cancer Classifier Assay for Men with Very Low & Low Risk Disease
MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs)
MolDX: GeneSight ® Assay for Refractory Depression
MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, & MTHFR)
MolDX: Genetic Testing
for
Lynch Syndrome & Other Inherited Colon Cancer Syndromes
MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
-FloridaBlue-
Molecular Analysis for Gliomas
MolDX: Guardant360 Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
MolDX:
HLA-B15:02
Genetic
Testing
MolDX:
HLA-DQB1*06:02 Testing for Narcolepsy
MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
MolDx: Testing for Lyme Disease & Other Vector Borne Illness
MolDX: MDS FISH
-Humana-
MolDX: Prometheus IBD sgi Diagnostic Policy
MolDX: MGMT Promoter Methylation Analysis
MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
MolDX: Molecular RBC Phenotyping
MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
MolDX: myPath Melanoma Assay
-UHC-
MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
MolDX: Oncotype DX Breast Cancer for DCIS
MolDX: Oncotype DX Genomic Prostate Score for Men with Favorable Intermediate Risk Prostate Cancer
MolDX: Percepta Bronchial Genomic Classifier
MolDX: Prolaris™ Prostate Cancer Genomic
Assay
MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
MolDX: ProMark Risk Score
MolDX: Prometheus IBD sgi Diagnostic Policy
Mutation Analysis in Myeloproliferative Neoplasms
RET Proto-Oncogene Testing
-Aetna-
Pharmaco-genetic Testing for Non-Cancer Indications
-Cigna-
Genetic Testing for Heritable Cardiac Conditions
-Anthem-
Tumor Genetic Markers
-FloridaBlue-
Copyright 2006-2023 Automated Clinical Guidelines, LLC. All rights reserved.
Home Contact FAQ
Account